Etodolac
- Product NDC
- 51672-4051
- 11-digit product format
- 516724051
- Labeler code
- 51672
- Product ID
- 51672-4051_28681979-a277-8b4c-e063-6394a90a2235
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Etodolac
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Taro Pharmaceuticals U.S.A., Inc.
- Application
- ANDA076174
- Marketing category
- ANDA
- Marketing start
- 2003-03-13
- Substance
- ETODOLAC
- Active strength
- 400 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Etodolac
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ETODOLAC | 400 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 2M36281008 |
| Rxcui | 310245, 310247, 359500 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 51672-4051-1 | Etodolac | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | | 7 |
| 51672-4051-2 | Etodolac | 500 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 500 | | 7 |
| 51672-4051-3 | Etodolac | 1000 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 1000 | | 7 |
| 51672-4051-4 | Etodolac | 60 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 60 | | 7 |
| 51672-4051-6 | Etodolac | 30 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 30 | | 7 |
| 51672-4051-9 | Etodolac | 10 in 1 CARTON | TABLET, EXTENDED RELEASE | 10 | | 7 |
| 51672-4051-9 | Etodolac | 6 in 1 BLISTER PACK | TABLET, EXTENDED RELEASE | 6 | | 7 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Etodolac | ACTIVE INGREDIENT | 2M36281008 | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Etodolac | ACTIVE MOIETY | 2M36281008 | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Aluminum Oxide | INACTIVE INGREDIENT | LMI26O6933 | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Anhydrous Lactose | INACTIVE INGREDIENT | 3SY5LH9PMK | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| FD&C Red No. 40 | INACTIVE INGREDIENT | WZB9127XOA | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| FD&C Yellow No. 6 | INACTIVE INGREDIENT | H77VEI93A8 | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Ferric Oxide Yellow | INACTIVE INGREDIENT | EX438O2MRT | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Hypromelloses | INACTIVE INGREDIENT | 3NXW29V3WO | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Indigotindisulfonate Sodium | INACTIVE INGREDIENT | D3741U8K7L | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Polydextrose | INACTIVE INGREDIENT | VH2XOU12IE | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Polyethylene Glycol 8000 | INACTIVE INGREDIENT | Q662QK8M3B | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Povidones | INACTIVE INGREDIENT | FZ989GH94E | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Triacetin | INACTIVE INGREDIENT | XHX3C3X673 | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 51672-4051 | ETODOLAC TABLET, EXTENDED RELEASE [TARO PHARMACEUTICALS U.S.A., INC.] | 7 | Current NDC, Legacy NDC, 7 package rows | 20241206_2c5b44b4-78d5-43b2-827d-d2763b6672b3.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51672-4051-1 | 51672405101 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-1) | | 2003-03-13 | 0000-00-00 | No | No | Current |
| 51672-4051-2 | 51672405102 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-2) | | 2003-03-13 | 0000-00-00 | No | No | Current |
| 51672-4051-3 | 51672405103 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-3) | | 2003-03-13 | 0000-00-00 | No | No | Current |
| 51672-4051-4 | 51672405104 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-4) | | 2003-03-13 | 0000-00-00 | No | No | Current |
| 51672-4051-6 | 51672405106 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (51672-4051-6) | | 2003-03-13 | 0000-00-00 | No | No | Current |
| 51672-4051-9 | 51672405109 | 10 BLISTER PACK in 1 CARTON (51672-4051-9) / 6 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | 10 blister pack | 2003-03-13 | 0000-00-00 | No | No | Current |